Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic Constipation
Status:
Completed
Trial end date:
1999-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether prucalopride is safe and effective in the
treatment of chronic constipation in elderly patients.
Hypothesis:
Prucalopride 2 mg and 4 mg given once daily for 12 weeks is superior to placebo for the
treatment of patients with chronic constipation and is well tolerated in those patients